S 652 is sponsored by Paul R. Heroux, Angelo M. Scaccia, James B. Eldridge (Democrat), Mike Connolly (Democrat), Kevin G. Honan (Democrat), Joan B. Lovely (Democrat), Elizabeth A. Malia, Denise Provost, Anne M. Gobi, Mark C. Montigny (Democrat), Jason M. Lewis (Democrat), José F. Tosado, Diana DiZoglio, Steven Ultrino (Democrat), Kenneth I. Gordon (Democrat), Harriette L. Chandler, Marjorie C. Decker (Democrat), James J. Dwyer, Kay Khan, Patricia D. Jehlen (Democrat), Michael D. Brady (Democrat), Robert M. Koczera, Colleen M. Garry (Democrat), Smitty Pignatelli, Antonio F. D. Cabral (Democrat), John F. Keenan (Democrat), Patrick M. O'Connor (Republican), James M. Cantwell, and James R. Miceli.

Where can I track S 652?

Track S 652 free on One Click Politics — get push/email alerts when it moves.

Massachusetts 190th Legislature (2017-2018) Status: In Committee Bipartisan · 14 D · 1 R cosponsors

S 652 — An Act to promote transparency and prevent price gouging of pharmaceutical drug prices

Last action May 31, 2018 — Accompanied a study order, see S2535

✓
Introduced
2
In Committee
3
Passed Senate
4
Passed House
5
To Executive
6
Enacted

This bill died with 190th Legislature (2017-2018). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

By Mr. Montigny, a petition (accompanied by bill, Senate, No. 652) of Mark C. Montigny, Jason M. Lewis, Jose F. Tosado, Diana DiZoglio and other members of the General Court for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.

Bill Text

We don't have the full text on file for this bill yet.

Read S 652 on the official Massachusetts source →

Action History

May 31, 2018
Accompanied a study order, see S2535
April 26, 2018
Senate concurred
April 24, 2018
Reporting date extended to Wednesday May 16, 2018, pending concurrence
March 01, 2018
House concurred
March 01, 2018
Reporting date extended to Wednesday April 25, 2018, pending concurrence
June 12, 2017
Hearing scheduled for 07/11/2017 from 11:00 AM-01:00 PM in B-1
January 23, 2017
House concurred
January 23, 2017
Referred to the committee on Health Care Financing

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 28 co-sponsors · 175 not signed on

Sponsors (1)

Mark C. Montigny Democrat

Not signed on (175)

175 members have not signed on to this bill.

Show all 175 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 652 do?: By Mr. Montigny, a petition (accompanied by bill, Senate, No. 652) of Mark C. Montigny, Jason M. Lewis, Jose F. Tosado, Diana DiZoglio and other members of the General Court for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
Who sponsors S 652?: S 652 is sponsored by Paul R. Heroux, Angelo M. Scaccia, James B. Eldridge (Democrat), Mike Connolly (Democrat), Kevin G. Honan (Democrat), Joan B. Lovely (Democrat), Elizabeth A. Malia, Denise Provost, Anne M. Gobi, Mark C. Montigny (Democrat), Jason M. Lewis (Democrat), José F. Tosado, Diana DiZoglio, Steven Ultrino (Democrat), Kenneth I. Gordon (Democrat), Harriette L. Chandler, Marjorie C. Decker (Democrat), James J. Dwyer, Kay Khan, Patricia D. Jehlen (Democrat), Michael D. Brady (Democrat), Robert M. Koczera, Colleen M. Garry (Democrat), Smitty Pignatelli, Antonio F. D. Cabral (Democrat), John F. Keenan (Democrat), Patrick M. O'Connor (Republican), James M. Cantwell, and James R. Miceli.
What is the current status of S 652?: This bill died with 190th Legislature (2017-2018). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track S 652?: Track S 652 free on One Click Politics — get push/email alerts when it moves.

Keep track of this bill

Add this bill to your alerts and we'll email you when it moves — or keep it on a watchlist and see it in your weekly digest.

Create a free account →

At a glance

Identifier: S 652
Jurisdiction: Massachusetts
Session: 190th Legislature (2017-2018)
Type: Bill
Introduced: January 23, 2017
Status: In Committee
Prime sponsor: Mark C. Montigny

Make your voice heard on S 652

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 652

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →